SynBio

Provectus Algae is an Australia-based biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics for use in a wide array of industries and applications. Provectus Algae enables groundbreaking capabilities with a well-balanced fusion of innovative proprietary technology and a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of their commercial partners.

Climate change is driving a transformative pivot in agriculture towards high-tech soilless greenhouses. These drastically reduce water use and emissions while significantly increasing yields. However, like humans need our gut microbiome, plants rely on the soil microbiome. This is missing in soilless agriculture, leading to reduced plant health and yield. Concert Bio addresses this by giving growers all the tools they need to create and manage an optimal microbiome in their system. Their proprietary platform gives growers unprecedented insights into their existing microbiome and uses that date to identify novel plant-beneficial microbes.

Farmless want to create a hopeful future by decoupling food production from arable land. They do this by cutting out the middle man of photosynthesis and replacing it with renewable energy to grow microbial protein with alcohol as a feedstock. Farmless can do this with 100-500x less land compared to animal proteins and 10-100x less land compared to plant proteins, independent from climate in a sustainable way.

Number 8 bio is a synthetic biology company engineering microbes to eliminate agricultural greenhouse gas emissions. Our team of synthetic biologists is developing innovative microbial solutions capable of reducing ruminant methane emissions, saving money for our farmers, and saving our climate.

The future of mRNA technology is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible Biotechnologies is on a journey to solve this problem by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA on demand.